Volgen
Stefan Kaluz
Stefan Kaluz
Department of Neurosurgery, Emory University
Geverifieerd e-mailadres voor emory.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Transcriptional control of the tumor-and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
S Kaluz, M Kaluzová, SY Liao, M Lerman, EJ Stanbridge
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (2), 162-172, 2009
3072009
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex
J Fan, C Shan, HB Kang, S Elf, J Xie, M Tucker, TL Gu, M Aguiar, ...
Molecular cell 53 (4), 534-548, 2014
2862014
Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element
S Kaluz, M Kaluzová, EJ Stanbridge
Clinica Chimica Acta 395 (1-2), 6-13, 2008
2332008
Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: a role for …
S Kaluz, M Kaluzová, A Chrastina, PL Olive, S Pastoreková, J Pastorek, ...
Cancer research 62 (15), 4469-4477, 2002
1872002
Hypoxia inducible factor pathway inhibitors as anticancer therapeutics
SK Burroughs, S Kaluz, D Wang, K Wang, EG Van Meir, B Wang
Future medicinal chemistry 5 (5), 553-572, 2013
1632013
Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1α C-terminal activation domain
S Kaluz, M Kaluzová, EJ Stanbridge
Molecular and cellular biology 26 (15), 5895-5907, 2006
1472006
DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1α in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX
M Kaluzová, S Kaluz, MI Lerman, EJ Stanbridge
Molecular and cellular biology 24 (13), 5757-5766, 2004
1172004
Genetic Interaction between Distinct Dobrava Hantavirus Subtypes in Apodemus agrarius and A. flavicollis in Nature
B Klempa, HA Schmidt, R Ulrich, S Kaluz, M Labuda, H Meisel, B Hjelle, ...
Journal of virology 77 (1), 804-809, 2003
1172003
Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer
S Kaluz, M Kaluzová, EJ Stanbridge
Cancer research 63 (5), 917-922, 2003
1052003
A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1
SM Cork, B Kaur, NS Devi, L Cooper, JH Saltz, EM Sandberg, S Kaluz, ...
Oncogene 31 (50), 5144-5152, 2012
922012
Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
S Yin, S Kaluz, NS Devi, AA Jabbar, RG de Noronha, J Mun, Z Zhang, ...
Clinical Cancer Research 18 (24), 6623-6633, 2012
882012
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines
N Shafee, S Kaluz, N Ru, EJ Stanbridge
Cancer letters 282 (1), 109-115, 2009
872009
Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement
KF Nolan, S Kaluz, KBM Reid, MP Dierich, W Schwaeble
European journal of immunology 21 (3), 771-776, 1991
791991
Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX: identification and characterization of a proximal silencer element
S Kaluz, M Kaluzová, R Opavský, S Pastoreková, A Gibadulinová, ...
Journal of Biological Chemistry 274 (46), 32588-32595, 1999
771999
Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster
K Kölble, J Lu, SE Mole, S Kaluz, KBM Reid
Genomics 17 (2), 294-298, 1993
771993
Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors
M Kaluzova, S PASTOREKOVÁ, E SVASTOVÁ, J PASTOREK, ...
Biochemical Journal 359 (3), 669-677, 2001
682001
Characterization of the human properdin gene
KF Nolan, S Kaluz, JMG Higgins, D Goundis, KBM Reid
Biochemical journal 287 (1), 291-297, 1992
571992
Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway
SR Mooring, H Jin, NS Devi, AA Jabbar, S Kaluz, Y Liu, EG Van Meir, ...
Journal of medicinal chemistry 54 (24), 8471-8489, 2011
562011
Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma
L Dong, S You, Q Zhang, S Osuka, NS Devi, S Kaluz, JH Ferguson, ...
Clinical Cancer Research 25 (7), 2206-2218, 2019
512019
Rational design of minimal hypoxia-inducible enhancers
S Kaluz, M Kaluzová, EJ Stanbridge
Biochemical and biophysical research communications 370 (4), 613-618, 2008
472008
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20